7 Biggest Price Target Changes For Tuesday
November 29, 2016 at 09:39 AM EST
Barclays cut BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) price target from $125 to $105. BioMarin Pharmaceutical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.